Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma

Ayu Nagamatsu(Kurume University Hospital), Naoto Shiba(Kurume University), Dan Nakano(Kurume University), Hayato Narao, Hiroo Matsuse(Kurume University), Manabu Tomita, Yuta Manako(Yamamoto Hospital), Shunji Koya(Kurume University Hospital), Ryuki Hashida(Kurume University), Noboru Koga, Takashi Niizeki(Kurume University), Takumi Kawaguchi(Kurume University), Yohei Kida(Kainan University), Daisuke Tanaka(Chienkuo Technology University), Keisuke Hirota(Kurume University Hospital), Takuji Torimura(Omuta hospital)
Hepatology Research
July 5, 2019
10.1111/hepr.13405
Cited by 30

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504